The Home of the Life Sciences Industry

Explore Latest News

Genentech and Hemophilia Patients Eye Oct. 4 for Hemlibra Ruling

Hemophilia patients could have an easier time taking their medication if the U.S. Food and Drug Administration gives the green light for the newest formulation of Genentech’s Hemlibra.

Novo Nordisk to Lay off 400 to Focus on Innovation

Novo Nordisk is laying off 400 staffers so it can shift funds toward biological and technological innovation.


Post jobs on BioSpace and start building your talent pipeline today. Click the button to access our easy eCommerce site, which lets you purchase and post jobs in just a few clicks.